ARID1A expression in the tumor of patients with pancreatic cancer decreased [17], and decreased ARID1A expression is associated with tumor stage/grade [17], lymphatic invasion/metastasis [19], and poor prognosis [17,19,20]. This evidence concerns the gene ARID1A and familial pancreatic carcinoma.